Ricardo Grillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ricardo Grillo has a total of 256 co-authors. Here are the top co-authors by number of shared publications:
Fernando Melhem-Elias
Faculty of Dentistry of the University of São Paulo, São Paulo-SP, Brazil
28 shared publicationsMariana Aparecida Brozoski
19 shared publications- Bernardo Correia Lima
Department of Oral and Maxillofacial Surgery, School of Dentistry University of São Paulo (FOUSP) São Paulo São Paulo Brazil
17 shared publications Sahand Samieirad
Assistant Professor, Department of Oral and Maxillofacial Surgery, University of Mashhad, Mashhad, Iran
15 shared publicationsMaria da Graça Naclério-Homem
Department of Oral and Maxillofacial Surgery, University of São Paulo, São Paulo, Brazil
14 shared publications- Mariana Aparecida Brozoski
University of São Paulo
14 shared publications
Latest Publications
- 10 November 2026
- Published by Wiley in Oral Diseases
Diagnostic Criteria Used in i‐ PRF Trials for Articular Temporomandibular Disorders: A Scoping Review
Objective: Injectable platelet‐rich fibrin (i‐PRF) is increasingly used for articular temporomandibular disorders (TMD), but it is unclear whether randomised controlled trials (RCTs) report validated diagnostic criteria for participant enrolment. This scoping review maps the diagnostic instruments reported in i‐PRF RCTs for articular TMD. It does not assess whether diagnostic systems were applied correctly or the accuracy of diagnoses. Methods: Following the JBI framework and PRISMA‐ScR, RCTs evaluating i‐PRF for articular TMD and reporting pain and/or maximum mouth opening were searched in six databases, without date or language restrictions, plus grey literature, trial registries and reference lists. Diagnostic approaches, sample characteristics, imaging, interventions, comparators, follow‐up and adverse events were charted. Results: Thirteen RCTs were included. Three reported DC/TMD for enrolment, two from the same research group. Five reported Wilkes staging, three reported imaging without a clinical diagnostic system, and two reported no diagnostic criterion. No trial reported RDC/TMD. Conclusion: Fewer than a quarter of i‐PRF RCTs reported enrolment using a currently validated diagnostic system. This methodological finding does not indicate whether i‐PRF is effective. Future trials should use DC/TMD and report diagnostic procedures in full.
- 10 November 2026
- Published by Wiley in Oral Diseases
Diagnostic Criteria Used in i‐ PRF Trials for Articular Temporomandibular Disorders: A Scoping Review
Objective: Injectable platelet‐rich fibrin (i‐PRF) is increasingly used for articular temporomandibular disorders (TMD), but it is unclear whether randomised controlled trials (RCTs) report validated diagnostic criteria for participant enrolment. This scoping review maps the diagnostic instruments reported in i‐PRF RCTs for articular TMD. It does not assess whether diagnostic systems were applied correctly or the accuracy of diagnoses. Methods: Following the JBI framework and PRISMA‐ScR, RCTs evaluating i‐PRF for articular TMD and reporting pain and/or maximum mouth opening were searched in six databases, without date or language restrictions, plus grey literature, trial registries and reference lists. Diagnostic approaches, sample characteristics, imaging, interventions, comparators, follow‐up and adverse events were charted. Results: Thirteen RCTs were included. Three reported DC/TMD for enrolment, two from the same research group. Five reported Wilkes staging, three reported imaging without a clinical diagnostic system, and two reported no diagnostic criterion. No trial reported RDC/TMD. Conclusion: Fewer than a quarter of i‐PRF RCTs reported enrolment using a currently validated diagnostic system. This methodological finding does not indicate whether i‐PRF is effective. Future trials should use DC/TMD and report diagnostic procedures in full.
- Open Access
- 15 October 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (6) , 103035
OrtogOnBlender XP and the integration of artificial intelligence in 3D virtual planning for orthognathic surgery
- 15 October 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (6) , 103035
Open AccessOrtogOnBlender XP and the integration of artificial intelligence in 3D virtual planning for orthognathic surgery
- 14 October 2026
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 22 (5) , 513-524
The critical role of maxillofacial surgeons in pain prevention and opioid consumption reduction
Objectives: Managing pain in oral and maxillofacial surgery (OMS) poses significant challenges due to the intricate nature of the procedures and extensive tissue manipulation. While opioids are often utilized for their strong analgesic effects, they carry serious risks, including a high potential for addiction and overdose-related fatalities. This paper aims to conduct a comprehensive literature review to explore effective, opioid-sparing pain management strategies in OMS, with a specific focus on evidence-based techniques that reduce reliance on opioids.Methods: A comprehensive literature review was conducted using PubMed, Web of Science, and Google Scholar databases, primarily focusing on the last 5 years (2019-2024) to ensure updated information, though seminal older works were also considered. The inclusion criteria focused on studies reporting alternatives to opioids for pain and discomfort control after OMS. Narrative reviews, editorials, and articles without a digital object identifier were excluded. Relevant data from the selected articles were extracted and analyzed.Results: A total of 4,306 articles were assessed, with 102 included in the review. The procedures reviewed included orthognathic surgery, maxillofacial trauma, reconstruction, dento-alveolar surgery, temporomandibular joint procedures, cleft palate surgery, and severe odontogenic infections. Thematic analysis revealed that the central question was answered affirmatively: Nonopioid strategies are effective in reducing opioid consumption. These strategies were found to maintain postoperative pain control while minimizing complications like post-operative nausea and vomiting. This review synthesizes the evidence to provide a clear hierarchy of recommended interventions.Conclusion: This review consolidates evidence indicating that a combination of stringent prescribing practices, multimodal analgesia, and regional anesthetic techniques can significantly reduce opioid dependence. To prevent opioid overprescription, it is essential to enforce strict regulatory measures, closely monitor prescriptions, establish regional guidelines, and avoid just-in-case prescribing. Effective strategies for improving post-operative outcomes and reducing opioid dependence include multimodal and pre-emptive analgesia, as well as post-operative anesthetic blocks. The findings provide a consolidated evidence base to guide maxillofacial surgeons in implementing these strategies, directly addressing the opioid crisis within the specialty.
- 14 October 2026
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 22 (5) , 513-524
The critical role of maxillofacial surgeons in pain prevention and opioid consumption reduction
Objectives: Managing pain in oral and maxillofacial surgery (OMS) poses significant challenges due to the intricate nature of the procedures and extensive tissue manipulation. While opioids are often utilized for their strong analgesic effects, they carry serious risks, including a high potential for addiction and overdose-related fatalities. This paper aims to conduct a comprehensive literature review to explore effective, opioid-sparing pain management strategies in OMS, with a specific focus on evidence-based techniques that reduce reliance on opioids.Methods: A comprehensive literature review was conducted using PubMed, Web of Science, and Google Scholar databases, primarily focusing on the last 5 years (2019-2024) to ensure updated information, though seminal older works were also considered. The inclusion criteria focused on studies reporting alternatives to opioids for pain and discomfort control after OMS. Narrative reviews, editorials, and articles without a digital object identifier were excluded. Relevant data from the selected articles were extracted and analyzed.Results: A total of 4,306 articles were assessed, with 102 included in the review. The procedures reviewed included orthognathic surgery, maxillofacial trauma, reconstruction, dento-alveolar surgery, temporomandibular joint procedures, cleft palate surgery, and severe odontogenic infections. Thematic analysis revealed that the central question was answered affirmatively: Nonopioid strategies are effective in reducing opioid consumption. These strategies were found to maintain postoperative pain control while minimizing complications like post-operative nausea and vomiting. This review synthesizes the evidence to provide a clear hierarchy of recommended interventions.Conclusion: This review consolidates evidence indicating that a combination of stringent prescribing practices, multimodal analgesia, and regional anesthetic techniques can significantly reduce opioid dependence. To prevent opioid overprescription, it is essential to enforce strict regulatory measures, closely monitor prescriptions, establish regional guidelines, and avoid just-in-case prescribing. Effective strategies for improving post-operative outcomes and reducing opioid dependence include multimodal and pre-emptive analgesia, as well as post-operative anesthetic blocks. The findings provide a consolidated evidence base to guide maxillofacial surgeons in implementing these strategies, directly addressing the opioid crisis within the specialty.
- 11 October 2026
- Published by Taylor & Francis in Cranio®
- p. 1-14
Hormonal imbalances and neuroendocrine influences in temporomandibular disorders: A scoping review of the evidence
Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and neuromuscular conditions affecting the temporomandibular joint (TMJ), masticatory muscles, and associated orofacia...
- 11 October 2026
- Published by Taylor & Francis in Cranio®
- p. 1-14
Hormonal imbalances and neuroendocrine influences in temporomandibular disorders: A scoping review of the evidence
Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and neuromuscular conditions affecting the temporomandibular joint (TMJ), masticatory muscles, and associated orofacia...
- Open Access
- 31 August 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (5)
Dangerous trends on social media related to facial esthetics: Analysis of looksmaxxing and its softmaxxing and hardmaxxing practices
- 31 August 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (5)
Open AccessDangerous trends on social media related to facial esthetics: Analysis of looksmaxxing and its softmaxxing and hardmaxxing practices
- Open Access
- 27 August 2026
- Published by Elsevier in Ethics, Medicine and Public Health
- Vol. 34
An integrated analysis of anecdotal evidence in dental social media and scientific literature
- 27 August 2026
- Published by Elsevier in Ethics, Medicine and Public Health
- Vol. 34
Open AccessAn integrated analysis of anecdotal evidence in dental social media and scientific literature
- Open Access
- 26 August 2026
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 53 (11) , 2190-2197
Understanding Diagnostic Failure in Temporomandibular Disorders: A Narrative Synthesis of Evidence and Five‐Domain Framework for Iatrogenic Mismanagement
Background: Diagnostic errors in temporomandibular disorders (TMDs) contribute to unnecessary procedures and avoidable patient mismanagement despite advances in pain science, diagnostic classification systems, and evidence‐based care. Objective: To conduct a narrative review and present a dynamic, five‐domain framework explaining how diagnostic uncertainty interacts with educational, cognitive, systemic, and ethical factors to produce iatrogenic overtreatment. Methods: Searches of PubMed, Scopus, Web of Science, and Google Scholar (inception to April 2026) identified literature on TMD diagnosis, clinical reasoning, dental education, health system organization, and bioethics. Concepts were synthesized into interacting thematic domains. Results: Five dynamic, interacting domains were identified: (1) Educational Deficits, (2) Structural Reductionism, (3) Occlusal Overinterpretation, (4) System Fragmentation, and (5) Ethical Dissonance. The model demonstrates how educational gaps foster reductionist diagnostic paradigms, which are amplified by health‐system silos and defensive clinical practices, increasing the likelihood of non‐indicated, irreversible interventions. Conclusions: The Five‐Domain Framework offers a systemic model for understanding diagnostic breakdown in TMD management, providing a structured foundation for educational reform, integrated care pathways, and future empirical research.
- 26 August 2026
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 53 (11) , 2190-2197
Open AccessUnderstanding Diagnostic Failure in Temporomandibular Disorders: A Narrative Synthesis of Evidence and Five‐Domain Framework for Iatrogenic Mismanagement
Background: Diagnostic errors in temporomandibular disorders (TMDs) contribute to unnecessary procedures and avoidable patient mismanagement despite advances in pain science, diagnostic classification systems, and evidence‐based care. Objective: To conduct a narrative review and present a dynamic, five‐domain framework explaining how diagnostic uncertainty interacts with educational, cognitive, systemic, and ethical factors to produce iatrogenic overtreatment. Methods: Searches of PubMed, Scopus, Web of Science, and Google Scholar (inception to April 2026) identified literature on TMD diagnosis, clinical reasoning, dental education, health system organization, and bioethics. Concepts were synthesized into interacting thematic domains. Results: Five dynamic, interacting domains were identified: (1) Educational Deficits, (2) Structural Reductionism, (3) Occlusal Overinterpretation, (4) System Fragmentation, and (5) Ethical Dissonance. The model demonstrates how educational gaps foster reductionist diagnostic paradigms, which are amplified by health‐system silos and defensive clinical practices, increasing the likelihood of non‐indicated, irreversible interventions. Conclusions: The Five‐Domain Framework offers a systemic model for understanding diagnostic breakdown in TMD management, providing a structured foundation for educational reform, integrated care pathways, and future empirical research.
- Open Access
- 17 August 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16 (4)
Biomimetic osteochondral regeneration of the TMJ condyle: integrating BMP-2 osteoinduction, MSC-mediated fibrochondrogenesis, and gradient 3D-printed scaffolds
- 17 August 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16 (4)
Open AccessBiomimetic osteochondral regeneration of the TMJ condyle: integrating BMP-2 osteoinduction, MSC-mediated fibrochondrogenesis, and gradient 3D-printed scaffolds
- Open Access
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
3D Bioprinting for Craniomaxillofacial Trauma Reconstruction: A Scoping Review
BackgroundCraniomaxillofacial (CMF) trauma reconstruction is highly challenging due to complex anatomy, intricate vascularisation requirements, and the limitations of traditional grafts. While patient-specific implants (PSI) provide anatomical contour, they lack biological responsiveness. Three-dimensional (3D) bioprinting offers a paradigm shift by depositing cell-laden bioinks to regenerate living, functional tissues.MethodsFollowing PRISMA-ScR guidelines and the Population, Concept and Context (PCC) framework, a systematic search was performed across PubMed, Embase, Web of Science, Scopus, and Google Scholar for studies up to May 2026. Data were qualitatively synthesised across 68 included primary studies to map the translational landscape.ResultsQualitative synthesis of the 68 included primary studies revealed that bioprinting research for CMF trauma remains heavily concentrated in preclinical stages (in vitro and small-animal in vivo models). Natural biopolymers (gelatin, alginate, collagen, fibrin) and semi-synthetic hydrogels (GelMA) were the dominant bioink backbones. Bioceramic incorporation consistently improved rheological printability and directed osteogenic commitment of human bone marrow stromal cells. Dual-polymer and cell-co-culture hydrogels supported cellular viability (>90%) and tissue-specific differentiation for epidermal and cartilaginous constructs. However, scaling constructs to human-sized CMF defects remains constrained by extrusion-induced shear mortality and passive oxygen diffusion limits (~100-200 µm), requiring sacrificial microchanneling or dynamic bioreactors. No fully cell-laden bioprinted constructs are currently approved for clinical CMF trauma repair.ConclusionWhile 3D bioprinting demonstrates high preclinical capability for generating osteogenic, chondrogenic, and soft-tissue constructs, its clinical transition for acute CMF trauma faces major hurdles in core necrosis, mechanical degradation under functional loads, and complex regulatory classifications. Future clinical translation will depend on standardized bioink formulations, integrated microvascular strategies, and point-of-care digital manufacturing workflows.
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open Access3D Bioprinting for Craniomaxillofacial Trauma Reconstruction: A Scoping Review
BackgroundCraniomaxillofacial (CMF) trauma reconstruction is highly challenging due to complex anatomy, intricate vascularisation requirements, and the limitations of traditional grafts. While patient-specific implants (PSI) provide anatomical contour, they lack biological responsiveness. Three-dimensional (3D) bioprinting offers a paradigm shift by depositing cell-laden bioinks to regenerate living, functional tissues.MethodsFollowing PRISMA-ScR guidelines and the Population, Concept and Context (PCC) framework, a systematic search was performed across PubMed, Embase, Web of Science, Scopus, and Google Scholar for studies up to May 2026. Data were qualitatively synthesised across 68 included primary studies to map the translational landscape.ResultsQualitative synthesis of the 68 included primary studies revealed that bioprinting research for CMF trauma remains heavily concentrated in preclinical stages (in vitro and small-animal in vivo models). Natural biopolymers (gelatin, alginate, collagen, fibrin) and semi-synthetic hydrogels (GelMA) were the dominant bioink backbones. Bioceramic incorporation consistently improved rheological printability and directed osteogenic commitment of human bone marrow stromal cells. Dual-polymer and cell-co-culture hydrogels supported cellular viability (>90%) and tissue-specific differentiation for epidermal and cartilaginous constructs. However, scaling constructs to human-sized CMF defects remains constrained by extrusion-induced shear mortality and passive oxygen diffusion limits (~100-200 µm), requiring sacrificial microchanneling or dynamic bioreactors. No fully cell-laden bioprinted constructs are currently approved for clinical CMF trauma repair.ConclusionWhile 3D bioprinting demonstrates high preclinical capability for generating osteogenic, chondrogenic, and soft-tissue constructs, its clinical transition for acute CMF trauma faces major hurdles in core necrosis, mechanical degradation under functional loads, and complex regulatory classifications. Future clinical translation will depend on standardized bioink formulations, integrated microvascular strategies, and point-of-care digital manufacturing workflows.
- Open Access
- 20 July 2026
- Published by Elsevier in SSRN Electronic Journal
Animal stings and venomous bites to the head and neck region: A practical guide with qualitative evidence synthesis
OBJECTIVES: To synthesize evidence on the clinical management of venomous animal accidents in the head and neck region and to propose a structured approach.METHODS: A systematic search was performed in PubMed, Web of Science, and Google Scholar up to May 2026. After screening, 49 studies were included and submitted to qualitative synthesis and CASP quality assessment.RESULTS: A total of 55 case reports were analyzed (arachnids: 18; reptiles: 19; insects: 18). The brown recluse spider was the main arachnid agent (66.7%), with progressive facial edema as the predominant local manifestation (77.8%). Snakes accounted for 18 of the 19 reptile cases, with airway obstruction occurring in 36.8%. Antibiotic therapy (73.7%) and antivenom administration (57.9%) were the most frequent interventions. Bees were the most common insect agent (55.6%), with ocular involvement predominating (44.4%). Most patients remained systemically asymptomatic (55.6%).CONCLUSION: Venomous accidents in the head and neck require early and structured management. There is a lack of specific protocols for arachnids and insects, highlighting the need for guidelines tailored to the craniofacial region that integrate airway assessment, edema monitoring, judicious antivenom therapy, and a multidisciplinary approach to optimize functional and aesthetic outcomes.
- 20 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAnimal stings and venomous bites to the head and neck region: A practical guide with qualitative evidence synthesis
OBJECTIVES: To synthesize evidence on the clinical management of venomous animal accidents in the head and neck region and to propose a structured approach.METHODS: A systematic search was performed in PubMed, Web of Science, and Google Scholar up to May 2026. After screening, 49 studies were included and submitted to qualitative synthesis and CASP quality assessment.RESULTS: A total of 55 case reports were analyzed (arachnids: 18; reptiles: 19; insects: 18). The brown recluse spider was the main arachnid agent (66.7%), with progressive facial edema as the predominant local manifestation (77.8%). Snakes accounted for 18 of the 19 reptile cases, with airway obstruction occurring in 36.8%. Antibiotic therapy (73.7%) and antivenom administration (57.9%) were the most frequent interventions. Bees were the most common insect agent (55.6%), with ocular involvement predominating (44.4%). Most patients remained systemically asymptomatic (55.6%).CONCLUSION: Venomous accidents in the head and neck require early and structured management. There is a lack of specific protocols for arachnids and insects, highlighting the need for guidelines tailored to the craniofacial region that integrate airway assessment, edema monitoring, judicious antivenom therapy, and a multidisciplinary approach to optimize functional and aesthetic outcomes.